Skip to main content
Category

Uncategorized

Emocha Coast to Coast

By Uncategorized

Dear friends,

Last Friday, the emocha team onboarded two of our newest video DOT partners: San Diego County and the State of Delaware. From Collin County, TX, to Columbus, OH, we’ve continued working with innovative tuberculosis programs to make directly observed therapy more convenient and cost-effective.

We’re taking all opportunities as we grow to gather user feedback and improve the emocha experience for patients and providers. That’s why earlier this month, our team visited the Puerto Rico Department of Health to learn how our technology has impacted their TB program.

In late 2016, the island was dealing with a TB outbreak in a facility for mentally impaired men. We volunteered the emocha platform pro bono to help manage the outbreak with Dr. Dana Thomas, then Medical Director, championing the effort on behalf of the TB program. Within months, all patients using emocha showed clinical signs of improvement.  

“emocha is so important because we have lost staff and fiscal resources over the years,” said Dr. Olga Joglar, TB Control Program Director.

In Puerto Rico and around the country, emocha helps public health departments save time and money on DOT programs. NIH-supported research shows that our platform for video observation can secure 92% adherence with significant cost savings.
 

READ MORE FROM THE NIH

The emocha platform is used worldwide for TB, HCV, HIV and opioid use disorder treatment. Ready to learn more? Visit our website or reach out at info@emocha.com

Image result for emocha

acousoft-logo.png

AcouSort

By Uncategorized

acousort.com

AcouSort is a Swedish company setting up a US presence. The company has a novel technology that uses acoustic fields to separate cells and particles to perform operations that is normally done by centrifugation in the biology or clinical lab.

acousoft-logo.png

nusep-logo.png

NuSep

By Uncategorized

shop.nusep.com

NuSep is a Life Sciences company that provides innovative tools that speed up and simplify protein separation, fractionation, and proteomic analysis. We also developing a novel clinical diagnostic platform to improve health outcomes.

nusep-logo.png

bionecure-logo.png

BiOneCure Therapeutics

By Uncategorized

www.bionecure.com

BiOneCure Therapeutics LLC is a biotechnology company committed to the discovery and development of innovative biotherapeutics for the treatment of cancer. The company is developing novel bispecific antibodies and a new class of antibody-drug conjugates (ADCs). Bispecific antibodies combine specificities of two different antibodies and are able to target two different antigens or epitopes simultaneously. ADCs are tumor-targeting antibodies chemically conjugated to a highly potent cytotoxic agent (warheads). Bispecific antibodies and ADCs promise huge potential for cancer therapy. A series of novel cytotoxic warheads being developed by BiOneCure feature new mechanisms of action for tumor cell killing and inhibition, which will enhance the therapeutic application and the safety of ADCs in clinical treatment of cancer patients. The company was founded in 2016 by industrial veterans and is based in Germantown, Maryland.

bionecure-logo.png

theraly-logo.png

Theraly

By Uncategorized

www.theraly.com

Theraly is a preclinical stage company that applies a novel, proprietary technology platform to create new drugs and improve existing drugs. Theraly aims to preserve the potency of peptides and small proteins while increasing their circulating half-lives.

theraly-logo.png

carradora-healt-logo-250.png

Carradora Health

By Uncategorized

www.carradora.com

Carradora Health, Inc. is a woman-owned small business dedicated to serving customers in healthcare information technology solutions in both the government and commercial spaces.  Our team has an exceptional background in providing personal service and innovative solutions on a variety of projects in Healthcare IT.

Current and recent projects for government clients center on research and development to enable the interoperability of electronic health records.  These efforts include subject areas such as testing and piloting patient-reported outcomes (PRO), developing long-term electronic services and supports, and improved standards around the Prescription Drug Monitoring Program (PDMP).

The expertise we provide covers a wide range of program support, including: working with standards development organizations (SDOs) to develop standards from PSS through to balloting and publishing, managing pilots with commercial and academic centers, convening in-person and on-line meetings of SMEs and other ranging from tens to hundreds of participants, healthcare IT vocabulary support.

Our team is committed to the advancement of Healthcare IT, and EHR interoperability in particular, in order to deliver better care to patients.

 

 

carradora-healt-logo-250.png

Akan Biosciences

By Uncategorized

Developing a proprietary technology for isolating and using adult stem cells for treatment of osteoarthritis and rheumatoid arthritis

Akan Biosciences

 

Reimbursement

By Uncategorized
  • Develop strategies to obtain payment in your target markets.
  • Demonstrate how your product improves outcomes and lowers costs for payers.
  • Identify existing codes or obtain new codes for reimbursement.

Regulatory, Preclinical /Clinical

By Uncategorized
  • Develop the best strategy to achieve regulatory approval and compliance.
  • Provide pre and post market risk assessment and mitigation services.
  • Work with the CRO’s with the greatest experience with patients addressed by your product and/or target market.

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.